IJERPH | Free Full-Text | Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in
the Real World: A Systematic Review and Meta-Analysis Next Article in Journal Cost and …

The vaccine and drug discovery responses to COVID-19 have worked far better than could
have been imagined. Yet by the end of 2021, more than 5 million people had died, and the …

Background Long-term effects of COVID-19, also called Long COVID, affect more than 10%
of patients. The most severe cases (ie those requiring hospitalization) present a higher …

As of January 2022, at least 60 million individuals are estimated to develop post-acute
sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome …

Importance The long-term health outcomes and symptom burden of COVID-19 remain
largely unclear. Objective To evaluate health outcomes of COVID-19 survivors 1 year after …

SARS-CoV-2 is a novel coronavirus that severely affects the respiratory system, is the cause
of the COVID-19 pandemic, and is projected to result in the deaths of 2 million people …

Alterations in brain functioning, especially in regions associated with cognition, can result
from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and are …

Long-term sequelae of coronavirus disease 2019 (COVID-19) due to infection with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now recognized. However …

Background In COVID-19 survivors a relatively high number of long-term symptoms have
been observed. Besides impact on quality of life, these symptoms (now called Post-COVID …

Coronavirus disease 2019 (COVID-19) has quickly become a global pandemic. Reports
from different parts of the world indicate that a significant proportion of people who have …